CD5, CD16, CD56, and CD57 were detected on tumor cells in γδT-LGL leukemia in 43% (6/14), 50% (7/14), 8% (1/13), and 64% (9/14) of cases, respectively. This evidence concerns the gene CD5 and neoplasm.